These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3082919)

  • 1. Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH.
    Nakamoto JM; Gertner JM; Press CM; Hintz RL; Rosenfeld RG; Genel M
    J Clin Endocrinol Metab; 1986 May; 62(5):822-6. PubMed ID: 3082919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
    Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
    Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB; Shulman D; Root AW; Spiliotis BE
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major.
    Pintor C; Cella SG; Manso P; Corda R; Dessĭ C; Locatelli V; Müller EE
    J Clin Endocrinol Metab; 1986 Feb; 62(2):263-7. PubMed ID: 3079770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.
    Rosenthal SM; Hulse JA; Kaplan SL; Grumbach MM
    J Clin Invest; 1986 Jan; 77(1):176-80. PubMed ID: 3080472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I.
    Blanchard MM; Goodyer CG; Charrier J; Barenton B
    Endocrinology; 1988 May; 122(5):2114-20. PubMed ID: 2896119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro.
    Silverman BL; Bettendorf M; Kaplan SL; Grumbach MM; Miller WL
    Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.